Author(s): P. K. Kumar, K. Govindasamy, G. Kumaresan, N. Sundar Raj


DOI: 10.5958/0974-360X.2020.00617.4   

Address: Dr. P. K. Kumar, K. Govindasamy*, Dr. G. Kumaresan, N. Sundar Raj
Department of Physical Education, Bharathiar University, Coimbatore, Tamil Nadu, India.
*Corresponding Author

Published In:   Volume - 13,      Issue - 7,     Year - 2020

In a survey conducted by Global Burden of Disease Study in the year 2010 it was found that the majority causes of death (around 29.6%) worldwide are due to CVDs. It is also predicted with the current growing rate that by the year 2030 the estimated deaths due to cardiac stroke will be more than 24 million of the world’s population. In this review, we have studied a lot of clinical trials and research papers which contribute to research findings and prove the benefits of usage of ayurvedic remedies since ages, medicinal herbs used by tribes, locals, vaidya’s and aryurvedic physicians on patients suffering from CAD. On a routine basis a lot of medicine shave been consumed by patients for treating chronic conditions of cardiovascular diseases and its associated complications. There is no denying of the fact that the herbal medicines, ayurvedic remedies and extracts have been a potential source of treating health conditions since old times. According to a research by WHO it was quoted that 80% of the population of world relies on natural products and traditional forms of medicines for treating ailments and health conditions.

Cite this article:
P. K. Kumar, K. Govindasamy, G. Kumaresan, N. Sundar Raj. A Critical Review on Traditional Medicines, Ayurvedic Herbs and fruits in Treatment of Cardiovascular Diseases. Research J. Pharm. and Tech. 2020; 13(7): 3480-3484. doi: 10.5958/0974-360X.2020.00617.4

P. K. Kumar, K. Govindasamy, G. Kumaresan, N. Sundar Raj. A Critical Review on Traditional Medicines, Ayurvedic Herbs and fruits in Treatment of Cardiovascular Diseases. Research J. Pharm. and Tech. 2020; 13(7): 3480-3484. doi: 10.5958/0974-360X.2020.00617.4   Available on:

1. Dorairaj. P.; Jeemon, P.; Roy, A. Cardiovascular diseases in India current epidemiology and future directions. Circulation. 2016; 133:1605–20.
2. Gupta, R.; Mohan, I; Narula, J. Trends in Coronary Heart Disease Epidemiology in India. Annals of Global Health. 2016; 82(2):307-315.
3. Ramachandran, S.; Emelia, V.; Benjamin, J. The Future of Cardiovascular Epidemiology. Circulation. 2016; 133:2626-2633.
4. Ashna, D.K.B.; Lewey, J.; Sagar, B.D; Niteesh, K.C. The Burden of Cardiovascular Disease in Low- and Middle-Income Countries: Epidemiology and Management. Canadian Journal of Cardiology. 2015; 31:1151-1159.
5. Lin, G.K. Cardiovascular epidemiology in the Asia–Pacific region. Asia Pacific J Clin Nutr. 2001; 10(2):76–80.
6. Kaur, P.; Rao, T.V.; Sankarasubbaiyan, S.; et al. Prevalence and Distribution of Cardiovascular Risk Factors in An Urban Industrial Population in South India: A Cross- Sectional Study. JAPI. 2007; 55:771-776.
7. Chauhan, S.; Bani, T.; The rising incidence of cardiovascular diseases in India: Assessing its economic impact. Preventive Cardiology. 2015; 4(4):735-740.
8. Syed, S.M.; Levy, D.; Ramachandran, S.V.; Thomas, J.W. The Framingham Heart Study and the Epidemiology of Cardiovascular Diseases: A Historical Perspective. Lancet. 2014; 383(9921):999–1008.
9. Gerald, M.; Oppenheimer. Framingham Heart Study: The First 20 Years. Progress in Cardiovascular Diseases. 2010; 53:55–61.
10. Srivastava, A.M.; Mohan, V.R.U.; Bachani, D. Obesity, Diabetes and Cardiovascular Diseases in India: Public Health Challenges. Current Diabetes Reviews. 2017; 13:65-80.
11. Chauhan, A.S.; Mukherjee, K. Economic burden of coronary heart disease in North India. Int J Non-Commun Dis. 2016; 1:18-25.
12. Unnikrishnan, R.; Mohan, R.A.; Mohan, V. Diabetes mellitus and its complications in India. Nature Reviews Endocrinology. 2016; 12:357-370.
13. A. Arya V, Gupta VK. Chemistry and Pharmacology of Plant Cardioprotectives: A Review. IJPSR. 2011; 2:1156–67.
14. B. Cohen PA, Ernst E. Safety of herbal supplements: a guide for cardiologists. J Cardiol Therap. 2010; 28:246–53.
15. D. Lin MC, Nahin R, Gershwin ME, Longhurst JC, Wu KK. State of complementary and alternative medicine in cardiovascular, lung, and blood research: executive summary of a workshop. Circulation. 2001; 103:2038–41.
16. E- S. Y. Jiang, J. C. Tong, R. Y. Sun, and H. T. Xie, “Meta-analysis of compound Danshen dropping pills(DSP) in treating coronary heart disease angina,” Practical Pharmacy and Clinical Remedies, vol. 10, no. 6, pp. 334–337, 2007. 
17. F. Zhou, S. W. Chan, H. L. Tseng et al., “Danshensu is the major marker for the antioxidant and vasorelaxation effects of Danshen (Salvia miltiorrhiza) water-extracts produced by different heat water-extractions,” Phytomedicine, vol. 19, no. 14, pp. 1263–1269, 2012. 
18. G. G. R. Zhao, H. M. Zhang, T. X. Ye et al., “Characterization of the radical scavenging and antioxidant activities of Danshensu and salvianolic acid B,” Food and Chemical Toxicology, vol. 46, no. 1, pp. 73–81, 2008. 
19. H. Q. T. Zhao, Q. M. Guo, P. Wang, and Q. Wang, “Salvianic acid A inhibits lipopolysaccharide-induced apoptosis through regulating glutathione peroxidase activity and malondialdehyde level in vascular endothelial cells,” Chinese Journal of Natural Medicines, Vol. 10, no. 1, pp. 53–57, 2012. 
20. I. G.-D. Yang, H. Zhang, R. Lin et al., “Down-regulation of CD40 gene expression and inhibition of apoptosis with Danshensu in endothelial cells,” Basic and Clinical Pharmacology and Toxicology, vol. 104, no. 2, pp. 87–92, 2009. 
21. J. Y. Guan, Y. Yin, Y.-R. Zhu et al., “Dissection of mechanisms of a Chinese medicinal formula: Danhong injection therapy for myocardial ischemia/reperfusion injury in vivo and in vitro,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 972370, 12 pages, 2013. 
22. K. B. L. Zhao, W. Jiang, Y. Zhao, J. W. Hou, and W. J. Xin, “Scavenging effects of salvia miltiorrhiza on free radicals and its protection for myocardial mitochondrial membranes from ischemia-reperfusion injury,” Biochemistry and Molecular Biology International, vol. 38, no. 6, pp. 1171–1182, 1996. 
23. L. X.-Y. Le, C.-L. Chen, L. Ma, N. Zhao, Y.-Q. Tang, and X.-Q. Liu, “Effects of Danshensu on the incidence of ischemia-reperfusion induced arrhythmia in hypertrophy rat heart,” Chinese Journal of Natural Medicines, vol. 6, no. 6, pp. 461–465, 2008. 
24. M. Y. Yin, Y. Guan, J. Duan et al., “Cardioprotective effect of Danshensu against myocardial ischemia/reperfusion injury and inhibits apoptosis of H9c2 cardiomyocytes via Akt and ERK1/2 phosphorylation,” European Journal of Pharmacology, vol. 699, no. 1-3, pp. 219–226, 2013. 
25. N. Agosti S, Casalino L, Bertero G, Barsotti A, Brunelli C, Morelloni S. A dangerous fruit juice. Am J Emerg Med. 2012; 30:248. E5–248.e8.
26. O. Kim EJY, Chen Y, Huang JQ, Li KM, Razmovski-Naumovski V, Poon J, et al. Evidence-based toxicity evaluation and scheduling of Chinese herbal medicines. J Ethnopharmacol. 2013; 146:40–61.
27. Simpson D. Buchu--South Africa's amazing herbal remedy. Scott Med J. 1998; 43:189–9.
28. Reinhart KM, Coleman CI, Teevan C, Vachhani P, White CM. Effects of garlic on blood pressure in patients with and without systolic hypertension: A meta-analysis. Ann Pharmacother. 2008; 42:1766–71.
29. Ried K, Frank OR, Stocks NP, Fakler P, Sullivan T. Effect of garlic on blood pressure: A systematic review and metaanalysis. BMC Cardiovasc Disord. 2008; 8:13.
30. Dhawan V, Jain S. Garlic supplementation prevents oxidative DNA damage in essential hypertension. Mol Cell Biochem. 2005; 275:85–94.
31. Hasrat JA, Pieters L, Vlietinck AJ. Medicinal plants in Suriname. J Pharm Pharmacol. 2004; 56:381–83
32. Z- Cohen PA, Ernst E. Safety of herbal supplements: a guide for cardiologists. J Cardiol Therap. 2010; 28:246–53.
33. Y- Gardner CD, Lawson LD, Block E, Chatterjee LM, Kiazand A, Balise RR, et al. Effect of raw garlic vs commercial garlic supplements on plasma lipid concentrations in adults with moderate hypercholesterolemia: a randomized clinical trial. Arc Intern Med. 2007; 167:346–53.
34. X- Ana H. Mota, A Review of Medicinal Plants Used in Therapy of Cardiovascular Diseases, International Journal of Pharmacognosy and Phytochemical Research 2016; 8(4); 572-591
35. Razmjouei D, Zarei Z, Akbari M. Ethnobotanical study of medicinal plants of Abadeh city in Fars province. Journal Plants Ecophysiology 2015; 7(3): 222-234.
36. Delfan B, Saki K, Bahmani M, Rangsaz N, Delfan M, Mohseni N, Shirzad H, Babaeian Z. A study on anti-diabetic and antihypertension herbs used in Lorestan province, Iran. J HerbMed Pharmacol. 2014; 3(2): 71-76.
37. Rahim-Forouzeh M, heshmati GHA, Barani H. Ethnobotanical survey of the province collected a selection of plants Kohgilouyeh. Medicine Journal of Islam and Iran 2015; 5(2): 131- 139
38. Khodayari H, Amani SH, Amiri H. Ethnobotanical study of North east of Khuzistan province. Med Plants Ecophytochemistry J 2013; 8; 2(4): 12-26.
39. Naghibi F, Esmaeili S, Malekmohammadi M, Hassanpour A, Mosaddegh M. Ethnobotanical survey of medicinal plants used traditionally in two villages of Hamedan, Iran. Avicenna Journal of Phytomedicine 2014; 1(3): 7-14.
40. Dolatkhahi M, I Nabipour. Ethnobotanical Study of Medicinal Plants Used in the Northeast Latrine Zone of Persian Gulf. JMP 2014, 2(50): 129-143.
41. Zolfaghari A, Adeli A, Mozafarian V, Babaei S, Habibi-Bibalan Gh. Identification of medicinal plants and indigenous knowledge of local people Arasbaran. J Med Arum Plants 2013; 28(3): 534- 550.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

56th percentile
Powered by  Scopus

SCImago Journal & Country Rank

Recent Articles


Not Available